LY75 and influenza: By conjunction with anti-DEC205 or anti-Clec12A antibodies, the OVA protein could provide efficient protection against influenza challenge, especially in the anti-DEC205 antibody fusion construct, indicating that CD103+ DCs could be a more important subtype of lung DCs than CD11b+ DCs.